Andreas Zori, MD
Dr. Zori has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship(s) to disclose.
CME Advisory Committee Disclosure:
Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/.
Release Date: September 4, 2020
Expiration Date: September 3, 2022
Primary Care Physicians, Specialty Physicians, and Physician Assistants
As a result of participation in this activity, participants should be able to:
- Describe prevalence of non-alcoholic fatty liver disease (NAFLD) and choose appropriate evaluation andmanagement for patients with NAFLD.
- Recognize when patients with NAFLD should be referred for specialist evaluation, identify unique nutritional needs of patients with NAFLD and cirrhosis.
- Determine which patients with cirrhosis should be referred for specialist evaluation. Recognize the significance of sarcopenia and frailty in prognosis for patients with cirrhosis.become familiar with assessment of frailty and sarcopenia.
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Resource for Further Study: Loomba, R. & Sanyal, A. J. Nat. Rev. Gastroenterol, Hepatol. 10, 686-690 (2013); published online 17 September 2013; doi:10.1.1038/nrgastro.2013.171
Contact Info: If you have any questions please feel free to contact Rhonda Tompkins at (352) 215-9541 or at email@example.com.
Section #: 1342, 2135, 3010